JP2025515091A5 - - Google Patents

Info

Publication number
JP2025515091A5
JP2025515091A5 JP2024564919A JP2024564919A JP2025515091A5 JP 2025515091 A5 JP2025515091 A5 JP 2025515091A5 JP 2024564919 A JP2024564919 A JP 2024564919A JP 2024564919 A JP2024564919 A JP 2024564919A JP 2025515091 A5 JP2025515091 A5 JP 2025515091A5
Authority
JP
Japan
Prior art keywords
approximately
eye
pharmaceutical composition
composition according
cfi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515091A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066620 external-priority patent/WO2023215840A1/en
Publication of JP2025515091A publication Critical patent/JP2025515091A/ja
Publication of JP2025515091A5 publication Critical patent/JP2025515091A5/ja
Pending legal-status Critical Current

Links

JP2024564919A 2022-05-04 2023-05-04 眼疾患を治療するための補体因子i投与レジメン Pending JP2025515091A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263338392P 2022-05-04 2022-05-04
US63/338,392 2022-05-04
PCT/US2023/066620 WO2023215840A1 (en) 2022-05-04 2023-05-04 Complement factor i dosing regimens for treating ocular diseases

Publications (2)

Publication Number Publication Date
JP2025515091A JP2025515091A (ja) 2025-05-13
JP2025515091A5 true JP2025515091A5 (cg-RX-API-DMAC7.html) 2026-05-14

Family

ID=86760162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564919A Pending JP2025515091A (ja) 2022-05-04 2023-05-04 眼疾患を治療するための補体因子i投与レジメン

Country Status (10)

Country Link
US (1) US20250177482A1 (cg-RX-API-DMAC7.html)
EP (1) EP4518881A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025515091A (cg-RX-API-DMAC7.html)
KR (1) KR20250008764A (cg-RX-API-DMAC7.html)
CN (1) CN119698286A (cg-RX-API-DMAC7.html)
AU (1) AU2023265150A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251504A1 (cg-RX-API-DMAC7.html)
IL (1) IL316772A (cg-RX-API-DMAC7.html)
TW (1) TW202400627A (cg-RX-API-DMAC7.html)
WO (1) WO2023215840A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3117551A1 (en) * 2018-10-23 2020-04-30 Gemini Therapeutics Inc. Compositions and methods for treating age-related macular degeneration and other diseases
GB201821082D0 (en) * 2018-12-21 2019-02-06 Gyroscope Therapeutics Ltd Combination of complement factors i and h, and vector encoding thereof
WO2021257480A2 (en) * 2020-06-14 2021-12-23 Catalyst Biosciences, Inc. Complement factor i-related compositions and methods

Similar Documents

Publication Publication Date Title
US9044436B2 (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
US9662371B2 (en) Treatment of autism and similar disorders
JP2015520188A5 (cg-RX-API-DMAC7.html)
JP2020524139A5 (cg-RX-API-DMAC7.html)
JP2016514132A5 (cg-RX-API-DMAC7.html)
WO2021021931A1 (en) Materials and methods for treating friedreich's ataxia
CN119421702A (zh) 替尔泊肽组合物和用途
CA2032859C (en) Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
EP1846022B1 (en) Methods for treating adhesive capsulitis
CN112888453A (zh) 用于治疗再生障碍性贫血的药物组合物
US11033607B2 (en) Peptides and methods for preventing ischemic tissue injury
JP2019504007A (ja) 糖尿病を治療するための医薬製剤
JP2023551193A (ja) 抗体関連型拒絶反応を処置するための方法
US20240424055A1 (en) Administration of c5-binding proteins
CN118973600A (zh) 用于脐带血移植后的血细胞恢复的药物组合物
JPH03291236A (ja) 感作t細胞関与疾患の治療剤
JP7621411B2 (ja) 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品
Ciulla et al. Avacincaptad pegol. Complement C5 inhibitor, Treatment of geographic atrophy secondary to dry age-related macular degeneration, Treatment of Stargardt disease
Wong What's new in contemporary ophthalmic drug delivery systems: Understanding the latest innovative technologies.
TW202535943A (zh) 改善抗FcRn療法之方法
HUP9901774A2 (hu) II Típusú kollagént tartalmazó gyógyszerkészítmények reumaszerű ízületi gyulladás kezelésére
Syringe DIAPER RASH
Capsules NEW DRUG APPROVALS
Kobayashi et al. WSAAI 50th Annual Scientific Session, Kohala Coast, Hawaii, January 20–24, 2013
IL266163B2 (en) Pharmaceutical composition and method of treating female sexual dysfunctions